Fractional killing arises from cell‐to‐cell variability in overcoming a caspase activity threshold
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
When cells are exposed to death ligands such as TRAIL , a fraction undergoes apoptosis and a fraction survives; if surviving cells are re‐exposed to TRAIL , fractional killing is once again observed. Therapeutic antibodies directed against TRAIL receptors also cause fractional killing, even at saturating concentrations, limiting their effectiveness. Fractional killing arises from cell‐to‐cell fluctuations in protein levels (extrinsic noise), but how this results in a clean bifurcation between life and death remains unclear. In this paper, we identify a threshold in the rate and timing of initiator caspase activation that distinguishes cells that live from those that die; by mapping this threshold, we can predict fractional killing of cells exposed to natural and synthetic agonists alone or in combination with sensitizing drugs such as bortezomib. A phenomenological model of the threshold also quantifies the contributions of two resistance genes (c‐ FLIP and Bcl‐2), providing new insight into the control of cell fate by opposing pro‐death and pro‐survival proteins and suggesting new criteria for evaluating the efficacy of therapeutic TRAIL receptor agonists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Luo, X., Budihardjo, I., Zou, H., Slaughter, C., & Wang, X. (1998) · Cell · doi:10.1016/s0092-8674(00)81589-5 · Cited by 3,626 · cited 2×
“…Sun et al, 2002; Barnhart et al, 2003) and the consequent translocation of cytochrome c and SMAC into the cytosol (Goldstein et al, 2000), where SMAC binds to and inactivates XIAP, thereby relieving XIAP-mediated caspase-3/7 inhibition (Luo et al, 1998; Li et al, 2002; Riedl & Salvesen, 2007).”
The apoptosome: Signalling platform of cell death
Riedl, S. J., & Salvesen, G. S. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2153 · Cited by 1,097 · cited 2×
“…Sun et al, 2002; Barnhart et al, 2003) and the consequent translocation of cytochrome c and SMAC into the cytosol (Goldstein et al, 2000), where SMAC binds to and inactivates XIAP, thereby relieving XIAP-mediated caspase-3/7 inhibition (Luo et al, 1998; Li et al, 2002; Riedl & Salvesen, 2007).”
Chang, L., Kamata, H., Solinas, G., Luo, J.-L., Maeda, S., Venuprasad, K., Liu, Y.-C., & Karin, M. (2006) · Cell · doi:10.1016/j.cell.2006.01.021 · Cited by 706 · cited 1×
“…FLIP-L and FLIP-S isoforms were more abundant in bortezomib-treated than untreated cells (2.5-fold and 3.5-fold, respectively; Fig 6C), reflecting the fact that, like C8, FLIP proteins are degraded by ubiquitin-dependent proteolysis (Poukkula et al, 2005; Chang et al, 2006; Laussmann et al, 2012).”
InfluentialBarnhart, B. C., Alappat, E. C., & Peter, M. E. (2003) · Seminars in Immunology · doi:10.1016/s1044-5323(03)00031-9 · Cited by 419
Pukac, L., Kanakaraj, P., Humphreys, R., Alderson, R., Bloom, M., Sung, C., Riccobene, T., Johnson, R., Fiscella, M., Mahoney, A., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602487 · Cited by 306 · cited 1×
“When we imaged ICRP in cells exposed to mapatumumab, a therapeutic antibody that functions as a DR4 agonist (Pukac et al, 2005), we observed the same dynamics as in TRAIL-treated cells: dFR/dt rose monotonically in dying cells, whereas in surviving cells, it peaked at t = 2–4 h and then fell (Fig…”
Fricker, N., Beaudouin, J., Richter, P., Eils, R., Krammer, P. H., & Lavrik, I. N. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201002060 · Cited by 154 · cited 1×
“FLIP-L has a catalytically inactive caspase domain but can activate pro-C8 as part of a heterocomplex with native caspase; it therefore functions as a C8 inhibitor under most conditions but as an activator under conditions of ‘high’ receptor activation (Fricker et al, 2010).”
Adams, C., Totpal, K., Lawrence, D., Marsters, S., Pitti, R., Yee, S., Ross, S., Deforge, L., Koeppen, H., Sagolla, M., et al. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402306 · Cited by 148 · cited 3×
“It has previously been shown that the potency of anti-DR4/5 antibodies can be increased by cross-linking them with anti-Fc antibodies (Adams et al, 2008).”
Two CD95 tumor classes with different sensitivities to antitumor drugs
Algeciras-Schimnich, A., Pietras, E. M., Barnhart, B. C., Legembre, P., Vijayan, S., Holbeck, S. L., & Peter, M. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2034995100 · Cited by 118 · cited 1×
“…previously postulated to control the choice between MOMP-independent Type I and MOMP-dependent Type II apoptosis in response to Fas ligands (Algeciras-Schimnich et al, 2003) and to protein kinase CK2-mediated regulation of tBid cleavage (Hellwig et al, 2010), although we have not yet…”
Majkut, J., Sgobba, M., Holohan, C., Crawford, N., Logan, A. E., Kerr, E., Higgins, C. A., Redmond, K. L., Riley, J. S., Stasik, I., et al. (2014) · Nature Communications · doi:10.1038/ncomms4350 · Cited by 81 · cited 2×
“HeLa cells contain ~1.5 × 105 pro-C8 molecules per cell, and full inhibition of ICRP processing (k ≤ 10 7) occurred at a FLIP-S:pro-C8 ratio of ~2:3 which is consistent with the idea that FLIP-S has a similar affinity for the DISC as C8 (Scaffidi et al, 1999; Majkut et al, 2014).”
Influential
Cited by
Cell-to-cell variation in p53 dynamics leads to fractional killing.
Paek, A. L., Liu, J. C., Loewer, A., Forrester, W. C., & Lahav, G. (2016) · Cell · doi:10.1016/j.cell.2016.03.025 · Cited by 292
Challenges in measuring and understanding biological noise
Eling, N., Morgan, M. D., & Marioni, J. C. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0130-6 · Cited by 247
Quantitating drug-target engagement in single cells in vitro and in vivo
Dubach, J. M., Kim, E., Yang, K., Cuccarese, M., Giedt, R. J., Meimetis, L. G., Vinegoni, C., & Weissleder, R. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2248 · Cited by 87
Molecular subtype-specific responses of colon cancer cells to the SMAC mimetic Birinapant
Fichtner, M., Bozkurt, E., Salvucci, M., McCann, C., McAllister, K. A., Halang, L., Düssmann, H., Kinsella, S., Crawford, N., Sessler, T., et al. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-03232-z · Cited by 28
Centofanti, E., Oyler-Yaniv, A., & Oyler-Yaniv, J. (2025) · Molecular Biology of the Cell · doi:10.1091/mbc.e24-10-0438 · Cited by 4
Metadata
- Authors
- Roux, J., Hafner, M., Bandara, S., Sims, J. J., Hudson, H., Chai, D., & Sorger, P. K.
- Venue
- Molecular Systems Biology
- Published
- 2015-05
- Volume
- 11
- Issue
- 5
- Pages
- 803-803
- ISSN
- 1744-4292 (ISSN-L)
- OpenAlex
- W2153612800
- Cited by
- 139
- References
- 9
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fractional killing arises from cell‐to‐cell variability in overcoming a caspase activity threshold. https://app.cochat.ai/papers/10.15252/msb.20145584
- The paper
- Roux, J., Hafner, M., Bandara, S., Sims, J. J., Hudson, H., Chai, D., & Sorger, P. K. (2015). Fractional killing arises from cell‐to‐cell variability in overcoming a caspase activity threshold. Molecular Systems Biology. https://doi.org/10.15252/msb.20145584
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.